I’ve been in the financial advisory business for roughly 28 years—and for 28 of those years, I’ve had a challenging relationship with the notion of “business development”—or the shadier moniker by ...

As a leadership expert and executive coach, I am often asked, "Andriana, how do I give my team members 'negative' feedback in a way that they understand it is genuine and I am not critiquing them?" ...

For biotech and pharma companies advancing monoclonal antibody programs, the pressure to reach the clinic quickly has never been greater. But speed alone isn’t enough—early decisions made during ...